Published online 2020 Nov 7. doi: 10.3390/molecules25215186PMCID: PMC7664437PMID: 33171772 Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease Serena Silvestro,†Giovanni Schepici,†Placido Bramanti, and Emanuela Mazzon*Francesca Cardona, Academic EditorAuthor informationArticle notesCopyright and License informationDisclaimerGo to: Abstract Cannabidiol (CBD) is a non-psychoactive phytocannabinoid known for its beneficial effects including antioxidant and anti-inflammatory properties. Moreover, CBD is a compound with antidepressant, anxiolytic, anticonvulsantContinue reading “Possible Benefits of CBD on Certain Neurological disorders”
A Bird's Eye View of Fashion, Food, Travel, Culture, Beverage and Curiosity 